18 December 2017

EMA/809318/2017

EudraVigilance System v.1.3 Release Notes

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

About this document This document lists and briefly describes the following areas for the releases of the EudraVigilance system. This includes the EudraVigilance messaging system, the EVWEB interface and the EV post function:

   

What's New: The enhancements and other changes released (new feature). Known Issues: The issues that exist (open issue). Fixed Issues: The issues that are fixed (fixed issue). Points to Note: The important aspects to keep in mind (point to note).

Release date: 18th December 2017 Fixed Issues: Id

Description

Status

1

When using the ICSR Download functionality, limiting the search to non-

Closed

serious ICSRs did not always work as expected and users had sometimes retrieve serious ICSRs in their results too. (Note: no ICSRs were missing from the downloaded files but are rather duplicated, i.e. present in both search for non-serious and serious ICSRs) 2

Country filter in ICSR Download should allow entering more than one

Closed

country. 3

Business Rules 109 and 696 need to be enabled to correctly validate

Closed

consistency between Primary Source Country, Reporter Country and Reporter State for Spain. 4

Webtrader Users: not able to open a message received from another

Closed

user. 5

When reviewing ICSRs sent before 8 November 2017 in the Webtrader

Closed

Outbox, the associated ACKs could not be viewed from the Outbox. 6

Webtrader users were not able to open an ICSR message submitted

Closed

before 8 November 2017. Known Issues: Id

Description

Proposed workaround

Status

1

UTC Time zone offset is not stored in

N/A

Open

the database. 2

3

If a test result unit is set to “DF –

The “DF – Dosage Form” value

Dosage Form” an incorrect error

for Test Result Unit should not be

message is displayed.

selected.

Age at Time of Onset of Reaction /

Age at Time of Onset of Reaction

Event (D.2.2a) and Age of Parent

/ Event (D.2.2a) and Age of

(D.10.2.2a) fields may accept values

Parent (D.10.2.2a) should be set

greater than the limit of 150 and

<=150.

Open

Open

longer than 3 characters without returning a validation error. This causes the message not to be processed correctly.

EMA/809318/2017

Page 2/4

Id

Description

Proposed workaround

Status

4

If an acknowledgment for a re-routed

Acknowledgments sent for re-

Open

ICSR contains a lower case “ICSR

routed ICSRs should contain

Batch Number”, EVWEB does not stop

upper-case "ICSR Batch Number".

sending the re-routed original ICSR. 5

The "World Wide Case ID" field is

When nullifying an existing ICSR

case- sensitive when nullifying an

and when performing a search

ICSR and when filtering is applied in

using the ICSR Download screen,

the ICSR download screen.

the “World Wide Case ID” should

Open

match exactly the one in the original message. 6

The "Error Message or Comment"

N/A

Open

N/A

Open

ICSRs submitted in ICH E2B(R3)

For ICSRs that have this issue,

Open

format where the reaction or drug end

the end date should be left blank.

date is provided (in the same year of

The incomplete end date should

the reaction or drug start date) as an

then be provided in the field

incomplete format may result in the

“Additional Information on Drug”

ICSRs receiving a negative

for the drug end date or the “case

acknowledgement.

narrative” field for the reaction

section in acknowledgements sent by EVHUMAN contains the case ID instead of the EV Report ID. 7

If the field Parent Identification (D.10.1) is masked in the ICSR, it appears as blank in the exported RTF file.

8

end date. 9

The ICSR download option "PV

The ICSR download option "PV

obligations reports (L2A) & MLM

obligations reports (L2A) & MLM

reports" produce unexpected results

reports" have been disabled. The

(either more MLM cases than desired

2 ICSR download functionality

or fewer L2A cases than required).

should be run separately: L2A

Open

without filtering on drugs, MLM with filtering on substances as is performed presently. 10

An error may occur when importing

The “Safety reports” search option

ICH ICSR messages into the

in the ICSR section of EVWEB

workspace area of EVWEB from the

should be used instead of

ICSR search section. Other imports

importing ICSRs into the

into the workspace are not affected by

workspace area of EVWEB.

Open

this.

EMA/809318/2017

Page 3/4

Id

Description

Proposed workaround

Status

11

For XML files created by

N/A

Open

N/A

Under

EudraVigilance the non-mandatory field Reporter's telephone number (C.2.r.2.7) - is not created as recommended by the ICH E2B technical document when the data is marked as masked. When this field is masked it will be provided as follows: Performance of ICSR Download

12

functionality for MAH can vary during

monitoring

the day. The L2B access to case narratives is

13

by EMA N/A

Open

When manually creating/changing

Open

currently under final validation and will be enabled at the same time as the MAH eRMR is made available to users. 14

-

New

Saved L2A requests (json file) using filter for primary source country, generates list of all countries apart from those countries that are part of the request.

L2A filters that include primary source country users need to be aware that the full list of countries needs to be used and the ones of interest should be removed.

Points to Note: 1. It is recommended to use Google Chrome, Mozilla Firefox or Internet Explorer 11 as preferred internet browsers. 2. ICH regional data elements are not supported. Therefore ICSRs containing these non-EU regional data elements may not receive acknowledgements. Proposed workaround: Do not include non-EU regional data elements. 3. ICSR download requests pending for more than 2 days will be cancelled by EMA. Users are advised to re-run the ICSR down-load requests.

EMA/809318/2017

Page 4/4

Release notes - European Medicines Agency - Europa EU

Dec 18, 2017 - system. This includes the EudraVigilance messaging system, the EVWEB interface and the EV post function: •. What's New: The enhancements and other ... Status. 1. When using the ICSR Download functionality, limiting the search to non- serious ICSRs did not always work as expected and users had.

214KB Sizes 7 Downloads 238 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...